A lung-damaging bacterium turns the body's antibody response in its favor, according to a study published in the Journal of Experimental Medicine.
Researchers show how the body’s antibody response can protect-not destroy-the bacterium Pseudomonas aeruginosa (pictured).
A lung-damaging bacterium turns the body's antibody response in its favor, according to a study published in the Journal of Experimental Medicine.
Pathogenic bacteria are normally destroyed by antibodies, immune proteins that coat the outer surface of the bug, laying a foundation for the deposition of pore-forming "complement" proteins that poke lethal holes in the bacterial membrane. But despite having plenty of antibodies and complement proteins in their bloodstream, some people can't fight off infections with the respiratory bacterium Pseudomonas aeruginosa. And chronic infection can lead to a condition called bronchiectasis, characterized by persistent cough, shortness of breath, and chest pain.
A group of researchers at the University of Birmingham in England now find that the antibody response to Pseudomonas can get in its own way. In a subset of infected bronchiectasis patients with particularly poor lung function, they noticed an abundance of one specific type of antibody, called IgG2, which stripped the blood of its normal bug-killing capacity. The IgG2 proteins bound to extra-long sugars on the bacterial surface, a feature unique to the bugs infecting these patients. When these sugar-specific antibodies were removed, the blood's antibacterial prowess was restored.
Exactly how these IgG2 molecules protect the bug is unclear, but they may lure complement proteins away from more vulnerable parts of the bacterial surface. The discovery of antibodies that protect the bug instead of the person may help to explain why two vaccines based on these extra-long sugars resulted in worse disease in immunized individuals.
Reference: Wells TJ, et al. 2014. J. Exp. Med. doi:10.1084/jem.20132444
“Ongoing Assault”: How HHS Layoffs Have Eviscerated Infection Prevention Support Across the Nation
April 1st 2025Mass layoffs at HHS and CDC have gutted critical infection prevention programs, leaving frontline professionals overwhelmed, under-resourced, and desperate to safeguard public health.
Together We Rise: Why AORN Expo 2025 Is a Must for Every Perioperative Nurse
March 31st 2025From April 5 to 8, 2025, thousands of perioperative nurses will gather in Boston for the 2025 AORN Global Surgical Conference & Expo—a transformational experience designed to elevate nursing practice, build lifelong connections, and advance surgical care.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.